Report Description

This can be ascribed to the growing cloning approaches in different genetic applications like reproductive cloning and genetic cloning. Additionally, various new product launches in the cloning and mutagenesis market which will demand for cloning and mutagenesis kit along with government organizations are investing for stem cell research for the development of new treatment and therapy have significantly increased the demand for cloning and mutagenesis across different parts of the globe. Additionally, growing geriatric population across the globe which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cloning and mutagenesis, thereby fuelling the market growth through 2028. Besides, growing awareness about the advantages of using gene therapy and diagnosis, along with increasing healthcare expenditure on chronic diseases treatment across the globe, are further expected to support the cloning and mutagenesis market during the forecast period. In 2022, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.

Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fueling the Market Growth 

Increasing research and development regarding cloning and mutagenesis for the development of cancer therapies and other rare disorders is expected to create a lucrative growth of the market during the forecast period. Government organizations are focusing on developed infrastructure with higher profits. Different type of innovative and ethically accepted therapies available for cancer therapy along with an increasing development of new products, are expected to boost the market growth over the years. In May 2020, Takara Bio announced a collaboration with AGC Biologics and their businesses will collaborate on a prophylactic DNA vaccine against COVID-19 with AGC Biologics manufacturing the plasmid DNA intermediate for the vaccine. . as public-funded research are getting a boost from bodies such as the European Commission and the Japan Agency for Medical Research and Development. In 2020, an estimated 276,480 new cases of invasive breast cancer will be diagnosed in women in the U.S. as well as 48,530 new cases of non-invasive (in situ) breast cancer. The increasing cloning of genes for the synthesis of antibiotics, hormones, and vitamins, among others, for the treatment of issues such as cystic fibrosis, is propelling the market growth.

Increasing Investment by Government Organization is Driving the Market’s Growth

Important factors which are expected to create a lucrative growth of the market include a favourable funding scenario for gene synthesis and cloning services, along with technological advancement in the treatment, followed by research, subcloning services, and rising synergistic activities in the market. Increasing demand for gene therapy and growing adoption of novel and advanced DNA cloning technologies  are expected to create a lucrative growth of the market during forecast period. 


Download Free Sample Report

 

Market Segmentation

Global cloning & mutagenesis market can be segmented by gene type, by product type, by technique, by application, by end user and by region. Based on gene type, the market can be divided into Standard and Complex. Based on product type, the market can be divided into Cloning Kits and Mutagenesis Kits. Based on technique, the market can be segmented into Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, and Others. Based on application, the market can be segmented into Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, and Others. Based on end user, the market can be differentiated into Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. 

 

Market Players

Agilent Technologies, Inc., Eurofins Scientific SE, Sartorius AG, Collecta, Inc., Codex DNA Inc., Lonza Group AG, Charles River Laboratories International, Inc., TransGene Biotech Co. Ltd., Takara Bio, Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Cloning & Mutagenesis Market.

 

Recent Development

In Jan 2021, Codex DNA and Pfizer signed an early access collaboration and licencing agreement, which will allow Pfizer to use CodexDNA's novel enzymatic DNA synthesis technology in its research and development of mRNA-based vaccines and biotherapies and it will be responsible for further developing the technology.


In May 2020, GenScript just launched a GMP single-strand and double-strand DNA service to aid in the growth of gene and cell therapies. The announcement highlights GenScript's commitment to assisting entire non-viral cell therapy development through the IND-enabling and clinical stages.

·  

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         By Therapy

·         By Indication

·         By End User

·         By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key companies profiled

Agilent Technologies, Inc., Eurofins Scientific SE, Sartorius AG, Collecta, Inc., Codex DNA Inc., Lonza Group AG, Charles River Laboratories International, Inc., TransGene Biotech Co. Ltd., Takara Bio, Inc., Thermo Fisher Scientific Inc.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. 

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global cloning & mutagenesis market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Cloning & Mutagenesis Market, By Gene Type:

o      Standard

o      Complex

  • Cloning & Mutagenesis Market, By Product Type:

o      Cloning Kits

o      Mutagenesis Kits

·         Cloning & Mutagenesis Market, By Technique:

o      Topo PCR Cloning

o      Blunt End Cloning

o      Seamless Cloning

o      Site-Directed Mutagenesis

o      Others

·         Cloning & Mutagenesis Market, By Application:

o      Gene Synthesis

o      Gene Expression

o      Gene Therapy

o      Vaccine Research

o      Others

·         Cloning & Mutagenesis Market, By End User:

o      Pharmaceutical & Biotechnology Companies

o      Academic & Research Institutions

o      Others

·         Cloning & Mutagenesis Market, By Region:

o      North America

§  United States

§  Canada

§  Mexico

o      Europe

§  France

§  Germany

§  United Kingdom

§  Italy

§  Spain

o      Asia Pacific

§  China

§  India

§  Japan

§  South Korea

§  Australia

o      South America

§  Brazil

§  Argentina

§  Colombia

o      Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Cloning & Mutagenesis Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Cloning & Mutagenesis Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Cloning & Mutagenesis Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Gene Type (Standard v/s Complex)

5.2.2.     By Product Type (Cloning Kits v/s Mutagenesis Kits)

5.2.3.     By Technique (Topo PCR Cloning, Blunt End Cloning, Seamless Cloning, Site-Directed Mutagenesis, Others)

5.2.4.     By Application (Gene Synthesis, Gene Expression, Gene Therapy, Vaccine Research, Others)

5.2.5.     By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Others)

5.2.6.     By Region

5.2.7.     By Company (2022)

5.3.  Market Map

5.3.1.     By Gene Type

5.3.2.     By Product Type

5.3.3.     By Technique

5.3.4.     By Application

5.3.5.     By End User

5.3.6.     By Region

6.    North America Cloning & Mutagenesis Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Gene Type

6.2.2.     By Product Type

6.2.3.     By Technique

6.2.4.     By Application

6.2.5.     By End User

6.2.6.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Cloning & Mutagenesis Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Gene Type

6.3.1.2.2.             By Product Type

6.3.1.2.3.             By Technique

6.3.1.2.4.             By Application

6.3.1.2.5.             By End User

6.3.2.     Canada Cloning & Mutagenesis Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Gene Type

6.3.2.2.2.             By Product Type

6.3.2.2.3.             By Technique

6.3.2.2.4.             By Application

6.3.2.2.5.             By End User

6.3.3.     Mexico Cloning & Mutagenesis Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Gene Type

6.3.3.2.2.             By Product Type

6.3.3.2.3.             By Technique

6.3.3.2.4.             By Application

6.3.3.2.5.             By End User

7.    Europe Cloning & Mutagenesis Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Gene Type

7.2.2.     By Product Type

7.2.3.     By Technique

7.2.4.     By Application

7.2.5.     By End User

7.2.6.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Cloning & Mutagenesis Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Gene Type

7.3.1.2.2.             By Product Type

7.3.1.2.3.             By Technique

7.3.1.2.4.             By Application

7.3.1.2.5.             By End User

7.3.2.     Germany Cloning & Mutagenesis Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Gene Type

7.3.2.2.2.             By Product Type

7.3.2.2.3.             By Technique

7.3.2.2.4.             By Application

7.3.2.2.5.             By End User

7.3.3.     United Kingdom Cloning & Mutagenesis Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Gene Type

7.3.3.2.2.             By Product Type

7.3.3.2.3.             By Technique

7.3.3.2.4.             By Application

7.3.3.2.5.             By End User

7.3.4.     Italy Cloning & Mutagenesis Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Gene Type

7.3.4.2.2.             By Product Type

7.3.4.2.3.             By Technique

7.3.4.2.4.             By Application

7.3.4.2.5.             By End User

7.3.5.     Spain Cloning & Mutagenesis Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Gene Type

7.3.5.2.2.             By Product Type

7.3.5.2.3.             By Technique

7.3.5.2.4.             By Application

7.3.5.2.5.             By End User

8.    Asia-Pacific Cloning & Mutagenesis Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Gene Type

8.2.2.     By Product Type

8.2.3.     By Technique

8.2.4.     By Application

8.2.5.     By End User

8.2.6.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Cloning & Mutagenesis Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Gene Type

8.3.1.2.2.             By Product Type

8.3.1.2.3.             By Technique

8.3.1.2.4.             By Application

8.3.1.2.5.             By End User

8.3.2.     India Cloning & Mutagenesis Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Gene Type

8.3.2.2.2.             By Product Type

8.3.2.2.3.             By Technique

8.3.2.2.4.             By Application

8.3.2.2.5.             By End User

8.3.3.     Japan Cloning & Mutagenesis Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Gene Type

8.3.3.2.2.             By Product Type

8.3.3.2.3.             By Technique

8.3.3.2.4.             By Application

8.3.3.2.5.             By End User

8.3.4.     South Korea Cloning & Mutagenesis Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Gene Type

8.3.4.2.2.             By Product Type

8.3.4.2.3.             By Technique

8.3.4.2.4.             By Application

8.3.4.2.5.             By End User

8.3.5.     Australia Cloning & Mutagenesis Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Gene Type

8.3.5.2.2.             By Product Type

8.3.5.2.3.             By Technique

8.3.5.2.4.             By Application

8.3.5.2.5.             By End User

9.    South America Cloning & Mutagenesis Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Gene Type

9.2.2.     By Product Type

9.2.3.     By Technique

9.2.4.     By Application

9.2.5.     By End User

9.2.6.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Cloning & Mutagenesis Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Gene Type

9.3.1.2.2.             By Product Type

9.3.1.2.3.             By Technique

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Argentina Cloning & Mutagenesis Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Gene Type

9.3.2.2.2.             By Product Type

9.3.2.2.3.             By Technique

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     Colombia Cloning & Mutagenesis Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Gene Type

9.3.3.2.2.             By Product Type

9.3.3.2.3.             By Technique

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

10.  Middle East and Africa Cloning & Mutagenesis Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Gene Type

10.2.2.  By Product Type

10.2.3.  By Technique

10.2.4.  By Application

10.2.5.  By End User

10.2.6.  By Country

10.3.              MEA: Country Analysis

10.3.1.  South Africa Cloning & Mutagenesis Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Gene Type

10.3.1.2.2.           By Product Type

10.3.1.2.3.           By Technique

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  Saudi Arabia Cloning & Mutagenesis Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Gene Type

10.3.2.2.2.           By Product Type

10.3.2.2.3.           By Technique

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  UAE Cloning & Mutagenesis Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Gene Type

10.3.3.2.2.           By Product Type

10.3.3.2.3.           By Technique

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Developments

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Competitive Landscape

13.1.              Business Overview

13.2.              Product Offerings

13.3.              Recent Developments

13.4.              Financials (As Reported)

13.5.              Key Personnel

13.6.              SWOT Analysis

13.6.1.  Agilent Technologies, Inc.

13.6.2.  Eurofins Scientific SE

13.6.3.  Sartorius AG

13.6.4.  Collecta, Inc.

13.6.5.  Codex DNA Inc.

13.6.6.  Lonza Group AG

13.6.7.  Charles River Laboratories International, Inc.

13.6.8.  TransGene Biotech Co. Ltd.

13.6.9.  Takara Bio, Inc.

13.6.10.                Thermo Fisher Scientific Inc.

Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

Rising prevalence of chronic disorders along with the increasing demand for early detection of the chronic diseases like HIV, cancer, etc., are some of the major factors driving the growth of global cloning & mutagenesis market.

down-arrow

Agilent Technologies, Inc., Eurofins Scientific SE, Sartorius AG, Collecta, Inc., Codex DNA Inc., Lonza Group AG, Charles River Laboratories International, Inc., TransGene Biotech Co. Ltd., Takara Bio, Inc., Thermo Fisher Scientific Inc. are some of the leading players operating in the Global Cloning & Mutagenesis Market.

down-arrow

The mutagenesis kits segment is expected to dominate the global cloning & mutagenesis market during the forecast period.

down-arrow

North America region is expected to hold the largest share in the Global Cloning & Mutagenesis Market.

profile

Sakshi Bajaal

Business Consultant
Press Release

Cloning & Mutagenesis Market to be dominated by Gene Induced Immunotherapy type through 2028

Dec, 2022

Increasing prevalence of chronic and genetic diseases is expected to drive the growth of global cloning & mutagenesis in the forecast period, 2024-2028.